Indeterminacy of cannabis impairment and ∆9-tetrahydrocannabinol (∆9-THC) levels in blood and breath von Wurz, Gregory T., DeGregorio, Michael W.

Volltext

A comprehensive breath test that confirms recent use of inhaled cannabis within the impairment window von DeGregorio, Michael W., Wurz, Gregory T., Montoya, Edward, Kao, Chiao-Jung

Volltext

Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ8-tetrahydrocannabinol: case studies von Wurz, Gregory T., Montoya, Edward, DeGregorio, Michael W.

Volltext

Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential von Wurz, Gregory T., Kao, Chiao-Jung, DeGregorio, Michael W.

Volltext

Pharmacokinetics of selective estrogen receptor modulators von MORELLO, Karla C, WURZ, Gregory T, DEGREGORIO, Michael W

Volltext

Ospemifene, vulvovaginal atrophy, and breast cancer von Wurz, Gregory T, Soe, Lin H, DeGregorio, Michael W

Volltext

Ospemifene: A first-in-class, non-hormonal selective estrogen receptor modulator approved for the treatment of dyspareunia associated with vulvar and vaginal atrophy von DeGregorio, Michael W., Zerbe, Robert L., Wurz, Gregory T.

Volltext

Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: Implications for diagnostic microdosing von Wurz, Gregory T., DeGregorio, Michael W.

Volltext

Tecemotide: An antigen-specific cancer immunotherapy von Wurz, Gregory T, Kao, Chiao-Jung, Wolf, Michael, DeGregorio, Michael W

Volltext

Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause von Wurz, Gregory T, Kao, Chiao-Jung, DeGregorio, Michael W

Volltext

Response to: “Deceptive argumentation against diagnostic microdosing of anticancer drugs” by Dirk Theile and Gerd Mikus (Letter dated February 13, 2014) von Wurz, Gregory T., DeGregorio, Michael W.

Volltext

Antitumor effects of L-BLP25 antigen-specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model von Wurz, Gregory T, Gutierrez, Audrey M, Greenberg, Brittany E, Vang, Daniel P, Griffey, Stephen M, Kao, Chiao-Jung, Wolf, Michael, DeGregorio, Michael W

Volltext

Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast von Soe, Lin H, Wurz, Gregory T, Kao, Chiao-Jung, Degregorio, Michael W

Volltext

Assessing the Effects of Concurrent versus Sequential Cisplatin/Radiotherapy on Immune Status in Lung Tumor-Bearing C57BL/6 Mice von Kao, Chiao-Jung, Wurz, Gregory T, Lin, Yi-Chen, Vang, Daniel P, Griffey, Stephen M, Wolf, Michael, DeGregorio, Michael W

Volltext

Clarifying the pharmacodynamics of tecemotide (L-BLP25)-based combination therapy von Kao, Chiao-Jung, Wurz, Gregory T., Schroder, Andreas, Wolf, Michael, DeGregorio, Michael W.

Volltext

Antitumor effects of cisplatin combined with tecemotide immunotherapy in a human MUC1 transgenic lung cancer mouse model von Kao, Chiao-Jung, Wurz, Gregory T, Monjazeb, Arta M, Vang, Daniel P, Cadman, Timothy B, Griffey, Stephen M, Wolf, Michael, DeGregorio, Michael W

Volltext

SERMs: current status and future trends von Morello, Karla C., Wurz, Gregory T., DeGregorio, Michael W.

Volltext

Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice von Wurz, Gregory T., Read, Karla C., Marchisano-Karpman, Cristina, Gregg, Jeffrey P., Beckett, Laurel A., Yu, Qilu, DeGregorio, Michael W.

Volltext

In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer von Taras, Tracy L., Wurz, Gregory T., DeGregorio, Michael W.

Volltext

Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ von Namba, Ruria, Young, Lawrence J T, Maglione, Jeannie E, McGoldrick, Erik T, Liu, Stephenie, Wurz, Gregory T, DeGregorio, Michael W, Borowsky, Alexander D, MacLeod, Carol L, Cardiff, Robert D, Gregg, Jeffrey P

Volltext